Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Srivichaivejvivat PCLBKK:VIH-R 82 Cyclically Adjusted Price-to-FCF is 14.41 as of Aug. 31, 2026, which is 19% below its 10-year median of 17.79. GuruFocus rates BKK:VIH-R with a GF Score™ of 82/100 and a GF Value™ of ฿9.04 (Fairly Valued). The stock has 4 warning signs investors should review. Among 208 Healthcare Providers & Services companies, Srivichaivejvivat PCL ranks better than 59.13% on this metric.
The historical rank and industry rank for Srivichaivejvivat PCL's Cyclically Adjusted Price-to-FCF or its related term are showing as below:
BKK:VIH-R'
s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 13.24 Med: 17.79 Max: 37.74
Current: 15.09
During the past years, Srivichaivejvivat PCL's highest Cyclically Adjusted Price-to-FCF was 37.74. The lowest was 13.24. And the median was 17.79.
BKK:VIH-R's Cyclically Adjusted Price-to-FCF is ranked better than 59.13% of 208
companies
in the Healthcare Providers & Services industry
Industry Median: 18.605
vs BKK:VIH-R: 15.09
The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.
Srivichaivejvivat PCL's adjusted free cash flow per share data for the three months ended in Jun. 2026 was ฿0.153. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is ฿0.61 for the trailing ten years ended in Jun. 2026.
Shiller PE for Stocks: The True Measure of Stock Valuation
Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.
Srivichaivejvivat PCL Cyclically Adjusted Price-to-FCF Related Terms
Srivichaivejvivat PCL Cyclically Adjusted Price-to-FCF Historical Data
* Premium members only.
The historical data trend for Srivichaivejvivat PCL's Cyclically Adjusted Price-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:VIH-R vs HCA, THC, EHC: Cyclically Adjusted Price-to-FCF Comparison
For the Medical Care Facilities subindustry, Srivichaivejvivat PCL's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Srivichaivejvivat PCL Cyclically Adjusted Price-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Srivichaivejvivat PCL's Cyclically Adjusted Price-to-FCF distribution charts can be found below:
* The bar in red indicates where Srivichaivejvivat PCL's Cyclically Adjusted Price-to-FCF falls into.
Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
What does a Cyclically Adjusted Price-to-FCF of 14.41 mean?
Srivichaivejvivat PCL (BKK:VIH-R) has a Cyclically Adjusted Price-to-FCF of 14.41 as of Aug. 31, 2026. Cyclically Adjusted Price-to-FCF Ratio is the ratio of share price to a company's inflation-adjusted FCF per share over a 10-year period. View historical data on Srivichaivejvivat PCL and its competitors. This is 19% below median its historical median of 17.79. Over the past decade, Srivichaivejvivat PCL's Cyclically Adjusted Price-to-FCF has ranged from 13.24 to 37.74. According to the industry distribution chart, Srivichaivejvivat PCL ranks #85 out of 208 companies in the Healthcare Providers & Services industry, placing it in the top 40.9%.
Is Srivichaivejvivat PCL's Cyclically Adjusted Price-to-FCF too high?
Srivichaivejvivat PCL's current Cyclically Adjusted Price-to-FCF of 14.41 is 19% below median its 10-year median of 17.79. Over the past 10 years, this metric has ranged from a low of 13.24 to a high of 37.74. The Healthcare Providers & Services industry median Cyclically Adjusted Price-to-FCF is 18.61. Srivichaivejvivat PCL's value of 14.41 is 22.5% below this industry median. Based on the distribution chart, Srivichaivejvivat PCL ranks #85 out of 208 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Srivichaivejvivat PCL has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Srivichaivejvivat PCL's Cyclically Adjusted Price-to-FCF compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Srivichaivejvivat PCL ranks #85 out of 208 companies for Cyclically Adjusted Price-to-FCF. This puts Srivichaivejvivat PCL in the upper half of its industry. The industry median Cyclically Adjusted Price-to-FCF is 18.61. Srivichaivejvivat PCL's value of 14.41 is 22.5% below this benchmark. Historically, Srivichaivejvivat PCL's own Cyclically Adjusted Price-to-FCF has ranged from 13.24 to 37.74 over the past decade. While the company's 10-year median is 17.79 vs. the industry median of 18.61, Srivichaivejvivat PCL has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Price-to-FCF for a Healthcare Providers & Services company?
The median Cyclically Adjusted Price-to-FCF among Healthcare Providers & Services companies is 18.61, based on 208 companies in the industry. Companies in the top quartile (top 25%) have a Cyclically Adjusted Price-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, Cyclically Adjusted Price-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Srivichaivejvivat PCL's current Cyclically Adjusted Price-to-FCF of 14.41 is 22.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Price-to-FCF mean?
A high Cyclically Adjusted Price-to-FCF can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted Price-to-FCF Ratio is the ratio of share price to a company's inflation-adjusted FCF per share over a 10-year period. View historical data on Srivichaivejvivat PCL and its competitors. For the Healthcare Providers & Services industry, the median Cyclically Adjusted Price-to-FCF is 18.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Srivichaivejvivat PCL's current Cyclically Adjusted Price-to-FCF is 14.41, which is 19% below median its own 10-year median of 17.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Srivichaivejvivat PCL stock overvalued right now?
Based on GuruFocus' analysis, Srivichaivejvivat PCL (BKK:VIH-R) is currently considered Fairly Valued. The stock's GF Value™ is ฿9.04, compared to a current price of ฿8.79 — trading 2.8% below its estimated fair value. The current Cyclically Adjusted Price-to-FCF is 14.41, which is 19% below median its 10-year median of 17.79 and 22.5% below the Healthcare Providers & Services industry median of 18.61. Srivichaivejvivat PCL's overall GF Score™ is 82/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Price-to-FCF calculated?
Cyclically Adjusted Price-to-FCF is calculated from a company's financial statements. For Srivichaivejvivat PCL (BKK:VIH-R), the current Cyclically Adjusted Price-to-FCF is 14.41 as of Aug. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Srivichaivejvivat PCL (BKK:VIH-R) Overvalued in 2026?
Based on GuruFocus' analysis, Srivichaivejvivat PCL stock appears to be undervalued.
The current stock price of ฿8.79 is trading 2.8% below its estimated GF Value™ of ฿9.04.
GuruFocus considers Srivichaivejvivat PCL to be Fairly Valued.
Key valuation signals for BKK:VIH-R:
Cyclically Adjusted Price-to-FCF: 14.41 (19% below median its 10-year median of 17.79)
GF Value™: ฿9.04 vs. price of ฿8.79 (2.8% below fair value)
Industry Position: 22.5% below the Healthcare Providers & Services median (#85 of 208)
No single metric tells the full story. See the BKK:VIH-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Srivichaivejvivat PCL is engaged in hospital business. The company provides 24-hour medical treatment by specialized doctors, with services in the outpatient department (OPD) by specialized doctors until midnight. Specialized clinics are available, such as comprehensive laparoscopic surgery, orthopedic surgery, urology, vascular surgery, cardiology, nephrology and hemodialysis center, endocrinology, neurology, gastroenterology, pediatric clinic, obstetrics and gynecology clinic, emergency accident center, dental center, health check-up center, Thai Filos Anti-Aging Center. It operates in single segment of hospital business in Thailand only.
82GF Score
Get the complete analysis for BKK:VIH-R
Cyclically Adjusted Price-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:VIH-R has been successfully added to your 
